Medicines for Europe

Press Releases of this organisation

TITLEsort ascending ORGANISATION DATE TOPIC
Vigilance saves lives! More focus needed on sustainability and patient engagement Medicines for Europe 24 Jan 2018 Health & Consumers
Value Added Medicines: Time to adjust the HTA Decision Frameworks for more patient-centric innovation Medicines for Europe 05 Sep 2017 Health & Consumers
Value added medicines: Continuous innovation crucial to improve healthcare across Europe Medicines for Europe 21 Nov 2018 Health & Consumers
US interference unacceptable in EU legislative proposal for an SPC manufacturing waiver Medicines for Europe 22 Oct 2018 Health & Consumers
Supply chain commitment to tackling problem of medicine shortages Medicines for Europe 02 Mar 2018 Health & Consumers
SPC manufacturing waiver, Competition policy, Brexit, pharma incentives European Patent Office take centre stage at 14th Legal Affairs Conference Medicines for Europe 25 Apr 2018 Health & Consumers
SPC manufacturing waiver moves a step closer as influential European Parliament ENVI Committee supports reform Medicines for Europe 18 Sep 2018 Health & Consumers
SPC manufacturing waiver cannot be derailed by foreign vested interests Medicines for Europe 07 Feb 2019 Health & Consumers
Risk that European Council will “neuter” SPC manufacturing waiver and give foreign (non-EU) manufacturers strong advantage over EU-based manufacturers Medicines for Europe 12 Oct 2018 Health & Consumers
Report shows life sciences industry alliance is taking action to curb antimicrobial resistance, with more to come Medicines for Europe 18 Jan 2018 Health & Consumers, InfoSociety
Parliament’s Trade Committee votes for jobs and access to medicines with a comprehensive SPC Manufacturing Waiver! Medicines for Europe 04 Dec 2018 Health & Consumers
Parliament’s Health Committee (ENVI) introduces constructive amendments to SPC Manufacturing waiver vote in its official opinion to the Parliament’s Legal Committee (JURI). Medicines for Europe 28 Nov 2018 Health & Consumers
Oncology, the new era for biosimilar medicines Medicines for Europe 08 Sep 2017 Health & Consumers
New safeguards for patient safety as Falsified Medicines Directive comes into force Medicines for Europe 11 Feb 2019 Health & Consumers
Medicines for Europe welcomes Competitiveness Council discussion to stop delocalisation of medicine manufacturing. It is time to effectively position Europe as a global hub for the production of medicines. Medicines for Europe 30 Nov 2018 Health & Consumers
Medicines for Europe to join the ISPOR Issue Panel on value added medicines Medicines for Europe 05 Oct 2017 Health & Consumers
Medicines for Europe members publish disclosure of Transfers of Value to the healthcare community Medicines for Europe 22 Jun 2018 Health & Consumers
Medicines for Europe can contribute much more to improve healthcare sustainability than described in the OECD “Health at a Glance 2016” report Medicines for Europe 24 Nov 2016 Health & Consumers
Medicines for Europe calls for greater cooperation on value added medicines to improve patient-centric innovation Medicines for Europe 22 Nov 2017 Health & Consumers
Medicines for Europe announces new President, launches Access to Medicines campaign Medicines for Europe 10 Oct 2017 Health & Consumers
Latest Data Shows the Need to Promote Biosimilar and Value Added Medicines for Better Health Medicines for Europe 16 Jun 2017 Health & Consumers
IGBA launches a Biosimilar Medicines Information Campaign Medicines for Europe 01 Feb 2018 Health & Consumers
IGBA congratulates the Australian Government for maintaining their Biologics Naming Convention and for strengthening pharmacovigilance Medicines for Europe 29 Jan 2018 Health & Consumers
Health at a Glance Report highlights public value of generic, biosimilar and value added medicines Medicines for Europe 26 Nov 2018 Health & Consumers
Fulfilling the Biosimilar Promise: Report Highlights Key Principles in Support of a Sustainable Market Medicines for Europe 19 Sep 2016 Health & Consumers
Europe’s life science industry urges the UK and EU27 to safeguard patients’ access to medicines with a clear transition period and a future cooperation agreement after Brexit Medicines for Europe 28 Nov 2017 Health & Consumers, UK in Europe
European Organisation for Specialised Nurses (ESNO) launches switch management guide between similar biological medicines - a guide for nurses Medicines for Europe 26 Jun 2018 Health & Consumers
European Commission launches: “What I need to know about Biosimilar Medicines - Information for patients”, in 23 EU languages Medicines for Europe 29 Nov 2017 Health & Consumers
EU Semester Country Specific Recommendations: More Efficient Medicine Policies Needed for Patient Access Medicines for Europe 23 May 2017 Health & Consumers
EU Semester Country Specific Recommendations: Improve patient access to medicine and ensure healthcare sustainability Medicines for Europe 24 May 2018 Health & Consumers

Pages